Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

1.33
+0.155013.25%
Volume:2.05M
Turnover:2.64M
Market Cap:83.43M
PE:-1.11
High:1.38
Open:1.14
Low:1.13
Close:1.17
52wk High:3.82
52wk Low:1.06
Shares:62.96M
Float Shares:21.07M
Volume Ratio:1.92
T/O Rate:9.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:3.11
PE(LYR):-1.32

Loading ...

Connect Biopharma Announces Positive Topline Data From Its Phase 1 Study Of Intravenous (Iv) Rademikibart In Patients With Asthma Or Copd

Reuters
·
Mar 30

BRIEF-Rademikibart Demonstrates Best-In-Class Potential In Phase 3 Atopic Dermatitis Study

Reuters
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Insmed, United Therapeutics, CrowdStrike

Reuters
·
Mar 30

Connect Biopharma Highlights Positive Rademikibart Respiratory Trial Results

TIPRANKS
·
Mar 30

BUZZ-Connect Biopharma rises as eczema drug shows lasting benefit in China study

Reuters
·
Mar 30

Connect Biopharma says rademikibart hits EASI-75 in 96.6% in Phase 3 AD trial

Reuters
·
Mar 30

Connect Biopharma says Phase 1 IV rademikibart trial shows rapid FEV1 improvement in asthma, COPD

Reuters
·
Mar 30

Press Release: Connect Biopharma Announces $20.2 Million Private Placement Financing

Dow Jones
·
Mar 30

Connect Biopharma Holdings Ltd - Rademikibart Achieves Rapid, Durable Efficacy in Phase 3 Atopic Dermatitis Study Through 52 Weeks

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd - Rademikibart Well Tolerated With Safety Comparable to Placebo

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd - Rademikibart Well-Tolerated With No Serious or Severe Adverse Events

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd - Recruitment Ongoing for Phase 2 Seabreeze Stat Studies; Topline Data Expected Mid-2026

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd - Rademikibart 300 Mg Iv Push Produces Rapid Fev1 Improvement ≥200 Ml in Asthma and Copd

THOMSON REUTERS
·
Mar 30

Connect Biopharma Holdings Ltd expected to post a loss of CNY1.41 a share - Earnings Preview

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23